Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Hsu Chang

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Journal of Robotic Surgery|July 10, 2025
Predicting hemorrhagic complications in robotic-assisted partial nephrectomy for renal tumors: simplifying risk assessment with tumor diameter and depthI-Hung Shao, Chung-Lin Lee, Yu-Hsiang Lin, et al.
Chang Gung Medical Journal|November 7, 2012
Everolimus in metastatic renal cell carcinoma: preliminary experience from Chang Gung Memorial HospitalWen-Kuan Huang, Chuang-Chi Liaw, See-Tong Pang, et al.
Oncology Letters|August 22, 2024
Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancerI-Hung Shao, Tzu-Hsuan Chang, Ying-Hsu Chang, et al.
International Journal of Cancer|November 8, 2022
Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancerHung-Kai Chen, Po-Jung Su, Yan-Lin Wang, et al.
Science Translational Medicine|February 24, 2017
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2Lian Dee Ler, Sujoy Ghosh, Xiaoran Chai, et al.
Science Translational Medicine|August 9, 2013
Genome-wide mutational signatures of aristolochic acid and its application as a screening toolSong Ling Poon, See-Tong Pang, John R McPherson, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Journal of Robotic Surgery|July 10, 2025
Predicting hemorrhagic complications in robotic-assisted partial nephrectomy for renal tumors: simplifying risk assessment with tumor diameter and depthI-Hung Shao, Chung-Lin Lee, Yu-Hsiang Lin, et al.
Chang Gung Medical Journal|November 7, 2012
Everolimus in metastatic renal cell carcinoma: preliminary experience from Chang Gung Memorial HospitalWen-Kuan Huang, Chuang-Chi Liaw, See-Tong Pang, et al.
Oncology Letters|August 22, 2024
Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancerI-Hung Shao, Tzu-Hsuan Chang, Ying-Hsu Chang, et al.
International Journal of Cancer|November 8, 2022
Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancerHung-Kai Chen, Po-Jung Su, Yan-Lin Wang, et al.
Science Translational Medicine|February 24, 2017
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2Lian Dee Ler, Sujoy Ghosh, Xiaoran Chai, et al.
Science Translational Medicine|August 9, 2013
Genome-wide mutational signatures of aristolochic acid and its application as a screening toolSong Ling Poon, See-Tong Pang, John R McPherson, et al.
Pageof 10